Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 24, Issue 5-6, 2010, Pages 409-420

  Angeli, Franca S ^a   Amabile, Nicolas ^a   Shapiro, Mia ^a   Mirsky, Rachel ^a   Bartlett, Lauren ^b   Zhang, Yan ^a   Virmani, Renu ^b   Chatterjee, Kanu ^a   Boyle, Andrew ^a   Grossman, William ^a   Yeghiazarians, Yerem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CVPATH INSTITUTE   (United States)

Author keywords

Cardiac remodeling; Cytokine; Erythropoietin; Granulocyte colony stimulating factor; Myocardial infarction

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BONE MARROW CELL; CELL MOTILITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART; HEART VENTRICLES; MYOCARDIAL INFARCTION; MYOCARDIUM; STROKE VOLUME; SWINE;

EID: 79958222598     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-010-6263-7     Document Type: Article

References (39)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2008;117:e25-146.
2. Frantz S, Vallabhapurapu D, Tillmanns J, et al. Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. Eur J Heart Fail. 2008;10:119-24. (Pubitemid 351221387)
3. Dawn B, Guo Y, Rezazadeh A, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res. 2006;98:1098-105.
4. Piepoli MF, Vallisa D, Arbasi M, et al. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). Eur J Heart Fail. 2010;12:172-80.
5. Yeghiazarians Y, Zhang Y, Prasad M, et al. Injection of Bone Marrow Cell Extract Into Infarcted Hearts Results in Functional Improvement Comparable to Intact Cell Therapy. Mol Ther 2009;
6. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98:10344-9. (Pubitemid 32803022)
7. Iwanaga K, Takano H, Ohtsuka M, et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun. 2004;325:1353-9. (Pubitemid 39535912)
8. Angeli FS, Smith C, Amabile N, Shapiro M, Bartlett L, Virmani R, et al. Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction. Cytokine. 2010;51:278-85.
9. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2008;156:216-26 e9.
10. Sterin-Borda L, Barcelo AC, Bozzini CE. Erythropoietin improves cardiac contractility in post-hypoxic mice. Br J Haematol. 2003;121:180-6. (Pubitemid 36461287)
11. Rui T, Feng Q, Lei M, et al. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res. 2005;65:719-27. (Pubitemid 40138993)
12. Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A. 2003;100:4802-6. (Pubitemid 36457809)
13. van der Meer P, Lipsic E, Henning RH, et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol. 2005;46:125-33. (Pubitemid 40905140)
14. Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, van Veldhuisen DJ. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail. 2008;10:22-9.
15. Angeli FS, Amabile N, Burjonroppa S, et al. Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction. J Card Fail. 2010;16:579-89.
16. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem. 2002;277:29355-8. (Pubitemid 41079217)
17. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999;20:254-7. (Pubitemid 29258161)
18. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl JMed. 2006;354:610-21. (Pubitemid 43209108)
19. Angeli FS, Shapiro M, Amabile N, et al. Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy. Comp Med. 2009;59:272-9.
20. Lipsic E, van der Meer P, Voors AA, et al. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study. Cardiovasc Drugs Ther. 2006;20:135-41. (Pubitemid 43876097)
21. Powell J, Gurk-Turner C. Darbepoetin alfa (Aranesp). Proc (Bayl Univ Med Cent). 2002;15:332-5.
22. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
23. Kass DA, Midei M, Graves W, Brinker JA, Maughan WL. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn. 1988;15:192-202. (Pubitemid 18261886)
24. Grossman W, Braunwald E, Mann T, McLaurin LP, Green LH. Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation. 1977;56:845-52. (Pubitemid 8235193)
25. Sunagawa K, Maughan, W., Suga, H., Sugawa, K. Cardiac contraction and the pressure-volume relationship. Oxford: Oxford Univ.Press; 1988.
26. Baan J, Van der Velde ET. Sensitivity of left ventricular endsystolic pressure-volume relation to type of loading intervention in dogs. Circ Res. 1988;62:1247-58.
27. Baan J, van der Velde ET, de Bruin HG, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984;70:812-23. (Pubitemid 15205446)
28. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res. 1981;48:813-24.
29. Glower DD, Spratt JA, Snow ND, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994-1009. (Pubitemid 15035251)
30. Amado LC, Schuleri KH, Saliaris AP, et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J AmColl Cardiol. 2006;48:2116-24. (Pubitemid 44738440)
31. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Circulation. 2002;105:539-42. (Pubitemid 34262671)
32. Kass DA, Maughan WL. From 'Emax' to pressure-volume relations: a broader view. Circulation. 1988;77:1203-12.
33. Nordhaug D, Steensrud T, Korvald C, Aghajani E, Myrmel T. Preserved myocardial energetics in acute ischemic left ventricular failure-studies in an experimental pig model. Eur J Cardiothorac Surg. 2002;22:135-42. (Pubitemid 34743726)
34. de Boer RA, Pinto YM, Suurmeijer AJ, et al. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc Res. 2003;57:434-42. (Pubitemid 36144222)
35. Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65:446-56. (Pubitemid 40082487)
36. Balleari E, Rossi E, Clavio M, et al. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. Ann Hematol. 2006;85:174-80. (Pubitemid 43174272)
37. Rigolin GM, Porta MD, Ciccone M, et al. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells. Br J Haematol. 2004;126:501-7.
38. Yeghiazarians Y, Khan M, Angeli FS, et al. Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction. J Card Fail. 2010;16:669-78.
39. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001;37:1726-32.